Systematic review and meta-analysis of gemcitabine-based chemotherapy after FOLFIRINOX in advanced pancreatic cancer

Background: There are no randomized data to guide treatment decisions for patients with advanced pancreatic adenocarcinoma following first-line FOLFIRINOX. We performed a systematic review and meta-analysis of studies using gemcitabine-based chemotherapy after FOLFIRINOX to assess treatment efficacy...

Full description

Bibliographic Details
Main Authors: Victor H. F. de Jesus, Marcos P. G. Camandaroba, Vinicius F. Calsavara, Rachel P. Riechelmann
Format: Article
Language:English
Published: SAGE Publishing 2020-02-01
Series:Therapeutic Advances in Medical Oncology
Online Access:https://doi.org/10.1177/1758835920905408